Patents
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
05/2007
05/30/2007CN1972925A Substituted bisarylurea derivatives
05/30/2007CN1972918A 嘧啶衍生物 Pyrimidine derivatives
05/30/2007CN1318460C Novel conductive polymer, sensor applicating said polymer and method for applicating said sensor to detect target molecular
05/30/2007CN1318406C New barbituric acid derivatives, processes for their production and pharmaceutical agent containing same
05/30/2007CN1318403C Indoline derivatives substituted in the 6 position, their preparation and their use as medicaments
05/30/2007CN1318402C Pyrrolidine-2-carboxylic acid hydrozide derivatives for use as metalloprotease inhibitors
05/30/2007CN1318027C GABA enhancers in the treatment of diseases relating to reduced neurosteroid activity
05/29/2007US7223789 Heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them
05/29/2007US7223788 therapy for eating disorders, anorexigenic agents, antidiabetic agents, reducing weight in mammals, circadian rhythm disease, psychological disorders
05/29/2007US7223785 Viral polymerase inhibitors
05/29/2007US7223782 Pyrazole-amides and -sulfonamides
05/29/2007US7223781 Immunomoderators; autoimmune disease; drug, cosmetics; antiinflammatory agnets
05/29/2007US7223777 Such as 1-(2-thien-2'-yl- 2-oxoethyl)-3-((3-phenylmethyl) pyrazol-5-yl)pyridinium bromide for treating diseases caused by the accumulation of AGE (Advanced Glycation Endproducts); antidiabetic/ antiaging agents
05/29/2007US7223768 Fused ring heterocycles as potassium channel modulators
05/29/2007US7223757 Such as (S)-4-[2-(3-Chloro-phenyl)-2-hydroxy-ethylamino]-3-{6-[4-(2-methoxy-ethyl)-piperazin-1-yl]-4-methyl-1H-benzimidazol-2-yl}-1H-pyridin-2-one bis hydrochloride; anticancer agents; antiproliferative agents
05/29/2007US7223738 Inhibitors of Akt activity
05/29/2007CA2214565C New cryptophycins from synthesis
05/29/2007CA2190659C Taxoids, preparation and pharmaceutical compositions containing them
05/24/2007WO2007058602A2 Novel 2-amino-imidazole-4-one compounds and their use in the manufacture of a medicament to be used in the treatment of cognitive impairment, alzheimer’s disease, neurodegeneration and dementia.
05/24/2007WO2007058601A1 Novel 2-amino-imidazole-4-one compounds and their use in the manufacture of a medicament to be used in the treatment of cognitive impairment, alzheimer’s disease, neurodegeneration and dementia
05/24/2007WO2007058392A1 Heterocyclic compound and medicinal application thereof
05/24/2007WO2007058346A1 HETEROCYCLIC COMPOUND HAVING INHIBITORY ACTIVITY ON 11-β-HYDROXYSTEROID DEHYDROGENASE TYPE I
05/24/2007WO2007058322A1 Basic group-containing compound and use thereof
05/24/2007WO2007057317A1 Novel pyrrolidine derivatives as inhibitors of coagulation factor xa
05/24/2007WO2007027527A3 Isoindole-imide compounds and compositions comprising and methods of using the same
05/24/2007WO2006119758B1 Dihydroxyphenylalanine derivatives
05/24/2007WO2006042150A8 Diaminoalkane aspartic protease inhibitors
05/24/2007US20070117858 Substituted 5-heteroaryl-1-phenyl-pyrazole cannabinoid modulators
05/24/2007US20070117847 N-(3-(4-Substituted-1-piperiding1)-1-phenylpropyl) substituted sulfonamides as NK-3 receptor antagonists
05/24/2007US20070117845 2-Pyridinylethylcarboxamide derivatives and their use as fungicides
05/24/2007US20070117817 Pyrimidine derivatives for treatment of hyperproliferative disorders
05/24/2007US20070117800 Pyrimidinyl-thiophene kinase modulators
05/24/2007US20070117795 Methods and compositions of novel triazine compounds
05/24/2007US20070117760 such as N-[5-({[5-({[3-(Dimethylamino)propyl]amino}carbonyl)-1-methyl-1H-pyrrol3-yl]amino}carbonyl)-1-isopropyl-1-H-pyrrol-3-yl]-4-[(3,3-dimethylbutanoyl)amino]-1-methyl-1H-pyrrole-2-carboxamide; oligopeptides; competitive binding
05/24/2007DE4327297B4 Verwendung von Piperidinverbindungen Using piperidine
05/24/2007CA2630680A1 Novel 2-amino-imidazole-4-one compounds and their use in the manufacture of a medicament to be used in the treatment of cognitive impairment, alzheimer~s disease, neurodegeneration and dementia.
05/24/2007CA2629080A1 Novel pyrrolidine derivatives as inhibitors of coagulation factor xa
05/24/2007CA2628461A1 Substituted 1h-benzimidazole-4-carboxamides are potent parp inhibitors
05/23/2007EP1787984A2 Azacyclic compounds for use in the treatment of serotonin related diseases
05/23/2007EP1787657A1 Therapeutic agent for psychoneurotic disease
05/23/2007EP1786804A1 Substituted indole compounds and their use as 5-ht6 receptor modulators
05/23/2007EP1786770A1 N-(1-(2,3-dihydro-1h-inden-5yl) -2-oxo-3-pyrrolidinyl) -sulfonamide derivatives for use as factor xa inhibitors
05/23/2007EP1786769A1 Compounds which potentiate glutamate receptor and uses thereof in medicine
05/23/2007EP1786427A2 Aliphatic amide & ester pyrazinoylguanidine sodium channel blockers
05/23/2007EP1651641B1 Nicotinamide derivatives useful as pde4 inhibitors
05/23/2007EP1476411B1 Method for producing 1,2-dichloroethane by direct chlorination
05/23/2007EP1370550B1 Quinolyl propyl piperidine derivatives, the preparation thereof and compositions containing same
05/23/2007EP1254895B1 Nitrogenous cyclic compounds and pharmaceutical compositions containing the same
05/23/2007CN1968987A Monomer, oligomer and pi-conjugated polymer compounds, and photovoltaic cells containing same
05/23/2007CN1968947A Heterocyclic condensed compounds useful as antidiuretic agents
05/23/2007CN1968929A Substituted tetrahydro-2h-isoquinolin-1-one derivatives, method for the production thereof, and use of the same as medicaments
05/23/2007CN1966501A Dendriform acetal ketal compound containing oxy, sulf heteroatom and its preparation method
05/23/2007CN1317278C Heterocyclic compounds and their use as medicines
05/23/2007CN1317277C Benzofuran derivatives and their use as antibacterial agents
05/23/2007CN1317274C 1-phenyl-2-heteroaryl-substituted benzimdazole derivatives, their use for the production of pharmaceutical agents as well as pharmaceutical preparations that contain these derivatives
05/23/2007CN1317273C Compound having thiofuran and acetylene ethylene bond, its preparation method and use
05/22/2007US7220862 Calcitonin gene related peptide receptor antagonists
05/22/2007US7220781 Meta-benzamidine derivatives as serine protease inhibitors
05/22/2007US7220773 Heterocylic amines used as antidiabetic or hyperglycemic agents
05/22/2007US7220771 Jun n-terminal kinase inhibitors
05/22/2007US7220770 preferably selectively inhibit cyclooxygenase-2 over cyclooxygenase-1; arthritis treament
05/22/2007US7220769 Azolylbenzamides and analogues and their use for treating osteoporosis
05/22/2007US7220763 Indole-type derivatives as inhibitors of p38 kinase
05/22/2007US7220760 1-carbonyl-4-carbonylaminotetrahydroquinoline derivatives; especially treating asthma and allergic rhinitis
05/22/2007US7220735 And aza- and diaza-derivatives thereof; especially treating allergy or nasal congestion
05/22/2007US7220734 1-(amino)indanes and (1,2-dihydro-3-amino)-benzofurans, benzothiophenes and indoles as Edg receptor agonists
05/22/2007US7220495 Luminescence device, display apparatus and metal coordination compound
05/22/2007CA2266050C Piperazine derivatives
05/22/2007CA2241263C N-arylsulfilimine compounds and their use as catalysts in the preparation of n-arylarylsulfonamide compounds
05/22/2007CA2212200C Novel inhibitors of .beta.-glucuronidase
05/18/2007WO2007056219A2 [4-(6-halo-7-substituted-2,4-dioxo-1,4-dihydro-2h-quinazolin-3-yl)-phenyl]-5-chloro-thiophen-2-yl-sulfonylureas and forms and methods related thereto
05/18/2007WO2007056167A2 Substituted-(quinazolinyl)phenyl thiophenyl-sulfonylureas, methods for making and intermediates thereof
05/18/2007WO2007056046A1 P2x7 receptor antagonists and methods of use
05/18/2007WO2007055183A1 Benzene derivative or salt thereof
05/18/2007WO2007054739A1 Tetrahydroindole derivatives for treatment of alzheimer's disease
05/18/2007WO2007054470A1 Use of rylene derivatives as photosensitizers in solar cells
05/18/2007WO2007054128A1 Novel inhibitors of the lfa-1/icam-1 interaction, and uses thereof
05/18/2007WO2007035841A9 Analogs of dehydrophenylahistins and their therapeutic use
05/18/2007WO2007029037A3 Class iia histone deacetylase (hdac) substrate
05/18/2007WO2007029036A3 Amino acid derivatives as histone deacetylase (hdac) inhibitors
05/18/2007WO2007029035A3 Thiophene and thiazole substituted trifluoroethanone derivatives as histone deacetylase (hdac) inhibitors
05/18/2007WO2007028083A3 6-arylalkylamino- 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists
05/18/2007WO2007002635B1 C-linked cyclic antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
05/18/2007WO2007002254A3 Benzocycloheptapyridines as inhibitors of the receptor tyrosine kinase met
05/18/2007CA2628934A1 Tetrahydroindole derivatives for treatment of alzheimer's disease
05/18/2007CA2627426A1 Carbocyclic fused cyclic amines as inhibitors of the coagulation factor xa
05/18/2007CA2627114A1 P2x7 receptor antagonists and methods of use
05/17/2007US20070112192 3-(2-Hydroxy-phenyl)-1h-pyrazole-4-carboxylic acid amide derivatives as hsp90 inhibitors for the treatment of cancer
05/17/2007US20070112063 e.g. 4-(3-Chlorophenylaminothiocarbonylamino)-3,4-dihydro-2,2-dimethyl-6-fluoro-2H-1-benzopyran; potassium channel activator; relaxant activity on smooth muscle cells; active on the pancreatic endocrine tissue as inhibitors of insulin secretion
05/17/2007US20070112040 Amino nicotinate derivatives as glucokinase (GLK) modulators
05/17/2007US20070112036 Opioid receptor antagonists
05/17/2007US20070112022 Piperidine derivatives as ccr5 receptor modulators
05/17/2007US20070112012 Carbocyclic fused cyclic amines
05/17/2007US20070112009 1-N-phenyl-amino-1h-imidazole derivatives and pharmaceutical compositions containing them
05/17/2007US20070112001 Treatment of thrombotic disorders, such as arterial and venous thrombosis, peripheral arterial occlusive disease, angina pectoris, myocardial infarction; (2S,4S)-4-[(5-chloro-thiophene-2-carbonyl)-amino]2-[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-pyrrolidine-1-carboxylic acid tert-butyl ester
05/17/2007US20070112000 Chemical compounds
05/17/2007US20070111988 Selective estrogen receptor modulators
05/16/2007EP1785417A2 Novel non-psychotropic cannabinoids
05/16/2007EP1784400A1 Histamine h3 receptor agents, preparation and therapeutic uses
05/16/2007EP1784392A2 Pyrimidine derivatives